116 related articles for article (PubMed ID: 946164)
21. Heterogeneity of sialoglycoproteins purified from normal and malignant cells.
Litin BS; Grimes WJ
Cancer Res; 1983 May; 43(5):2131-7. PubMed ID: 6831439
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the N-linked glycopeptides of DQw1 and DR1 molecules.
Iturbe S; Narasimhan S; Merrick JM; Falk JA; Letarte M
J Immunol; 1986 Jun; 136(12):4588-95. PubMed ID: 3486905
[TBL] [Abstract][Full Text] [Related]
23. Chemical and immunological studies of cell surfaces from normal and transformed cells.
Grimes WJ; Van Nest GA; Kamm AR
J Supramol Struct; 1977; 6(3):449-64. PubMed ID: 338994
[TBL] [Abstract][Full Text] [Related]
24. Glucocorticoid receptors and mechanism of resistance in the cortisol-sensitive and -resistant lines of lymphosarcoma P1798.
Kaiser N; Milholland RJ; Rosen F
Cancer Res; 1974 Mar; 34(3):621-6. PubMed ID: 4359883
[No Abstract] [Full Text] [Related]
25. Sialoglycopeptides isolated from human arteriosclerotic tissue.
Saito H; Ototani N; Yosizawa Z
J Biochem; 1975 May; 77(5):931-8. PubMed ID: 1158858
[TBL] [Abstract][Full Text] [Related]
26. Differences in cell surface characteristics between glucocorticoid-sensitive and -resistant mouse lymphomas.
Behrens UJ; Mashburn LT; Stevens J; Hollander VP; Lampen N
Cancer Res; 1974 Nov; 34(11):2926-32. PubMed ID: 4138432
[No Abstract] [Full Text] [Related]
27. Modification of cell surface carbohydrates and invasive behavior by an alkyl lysophospholipid.
Bolscher JG; Schallier DC; van Rooy H; Storme GA; Smets LA
Cancer Res; 1988 Feb; 48(4):977-82. PubMed ID: 3338089
[TBL] [Abstract][Full Text] [Related]
28. Correlation of retinoic acid-enhanced sialyltransferase activity and glycosylation of specific cell surface sialoglycoproteins with growth inhibition in a murine melanoma cell system.
Lotan R; Lotan D; Meromsky L
Cancer Res; 1984 Dec; 44(12 Pt 1):5805-12. PubMed ID: 6498840
[TBL] [Abstract][Full Text] [Related]
29. Glucocorticoid effects of lymphosarcoma P1798 on DNA replication and growth of subcutaneous tumors in mice.
Thompson EA; Moore WM; Sawyer RH
J Natl Cancer Inst; 1980 Aug; 65(2):477-83. PubMed ID: 6931263
[TBL] [Abstract][Full Text] [Related]
30. Sialoglycopeptides isolated from bovine aorta.
Saito H; Yosizawa Z
J Biochem; 1975 May; 77(5):919-30. PubMed ID: 1158857
[TBL] [Abstract][Full Text] [Related]
31. Insensitivity to the cytolytic effects of glucocorticoids in vivo is associated with a novel "slow death" phenotype.
Thompson EA
Cancer Res; 1991 Oct; 51(20):5544-50. PubMed ID: 1913673
[TBL] [Abstract][Full Text] [Related]
32. Presence of fucosyl residues on the oligosaccharide antennae of membrane glycopeptides of human neuroblastoma cells.
Santer UV; Glick MC
Cancer Res; 1983 Sep; 43(9):4159-66. PubMed ID: 6871857
[TBL] [Abstract][Full Text] [Related]
33. Cell surface sialic acid influences tumor cell recognition in the mixed lymphocyte reaction.
Powell LD; Whiteheart SW; Hart GW
J Immunol; 1987 Jul; 139(1):262-70. PubMed ID: 2953814
[TBL] [Abstract][Full Text] [Related]
34. Differences in nuclear glucocorticoid binding between corticoid-sensitive and corticoid-resistant lymphocytes of mouse lymphoma P1798 and stabilization of nuclear hormone receptor complexes with carbobenzoxy-L-phenylalanine.
Stevens J; Stevens YW; Rhodes J; Steiner G
J Natl Cancer Inst; 1978 Dec; 61(6):1477-85. PubMed ID: 281555
[No Abstract] [Full Text] [Related]
35. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
[TBL] [Abstract][Full Text] [Related]
36. Comparison of cell-surface glycoproteins of rat hepatomas and embryonic rat liver.
van Beek WP; Emmelot P; Homburg C
Br J Cancer; 1977 Aug; 36(2):157-65. PubMed ID: 199223
[TBL] [Abstract][Full Text] [Related]
37. Humoral immunostimulation. VII. Sialic acid masks antigenic sites on an antibody-selected bariant cell line.
Shearer WT; Gottlieb C; Kornfeld S
J Immunol; 1977 Aug; 119(2):614-7. PubMed ID: 69664
[TBL] [Abstract][Full Text] [Related]
38. Biochemical and molecular characterization of the glucocorticoid receptor of lymphosarcoma P1798 variants.
Lucas KL; Barbour KW; Housley PR; Thompson EA
Mol Endocrinol; 1988 Mar; 2(3):291-9. PubMed ID: 3398856
[TBL] [Abstract][Full Text] [Related]
39. The effects of monensin on blood-borne arrest and glycosylation of BL/VL3 lymphoma cells.
Di Virgilio S; Rampelberg M; Greimers R; Schnek G; Hooghe R
Cell Biochem Funct; 1992 Mar; 10(1):41-52. PubMed ID: 1349514
[TBL] [Abstract][Full Text] [Related]
40. Sequential irreversible, actinomycin D-sensitive, and cycloheximide-sensitive steps prior to cortisol inhibition of uridine utilization by P1798 tumor lymphocytes.
Stevens J; Stevens YW
Cancer Res; 1975 Aug; 35(8):2145-53. PubMed ID: 1149029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]